Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Obesity (Silver Spring). 2020 Oct;28(10):1984–1992. doi: 10.1002/oby.22933

Table 2.

PFAS plasma concentrations (ng/mL) and Spearman correlations between PFASs measured in Project Viva participants (n=1614)

PFAS % >LOD Geometric mean 25% median 75% 95%
PFOS 99.8 25.4 18.8 25.7 34.9 57.3
PFOA 100 5.7 4.2 5.9 7.9 12.1
PFHxS 99.3 2.5 1.6 2.5 3.8 9.1
PFNA 98.6 0.7 0.5 0.7 0.9 1.5
EtFOSAA 99.7 1.2 0.7 1.2 1.9 4.3
MeFOSAA 100 1.9 1.3 1.9 3.2 5.6
Correlation coefficients
PFOS PFOA PFHxS PFNA EtFOSAA MeFOSAA
PFOS 1.00
PFOA 0.71 1.00
PFHxS 0.50 0.52 1.00
PFNA 0.60 0.52 0.42 1.00
EtFOSAA 0.52 0.39 0.21 0.19 1.00
MeFOSAA 0.40 0.37 0.23 0.23 0.40 1.00
1

LOD: limit of detection (0.2 ng/mL for PFOS and 0.1 ng/mL for all other PFAS chemicals). Concentrations below the limit of detection were imputed as LOD/√2).

2

PFOA: perfluorooctanoic acid; PFOS: perfluorooctanesulfonic acid; PFNA: perfluorononanoic acid; PFHxS: perfluorohexane sulfonic acid; EtFOSAA: 2-(N-ethyl-perfluorooctane sulfonamido) acetic acid; MEFOSAA: 2-(N-methyl-perfluorooctane sulfonamido) acetic acid